Endurant Capital Management’s Orthofix Medical OFIX Stock Holding History

Endurant Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-434,803	Closed	-$14.2M	–	71
2022 Q1	$14.2M	Buy	434,803 +415,986	+2,211%	+$13.4M	3.75%	7
2021 Q4	$585K	Buy	+18,817	New	+$629K	0.14%	64
2018 Q4	–	Sell	-11,478	Closed	-$664K	–	69
2018 Q3	$664K	Buy	+11,478	New	+$643K	0.3%	57
2017 Q3	–	Sell	-30,400	Closed	-$1.41M	–	98
2017 Q2	$1.41M	Buy	+30,400	New	+$1.26M	0.4%	58

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Endurant Capital Management's OFIX Position: Q2 2022 in Review

Endurant Capital Management sold out of Orthofix Medical (OFIX) in Q2 2022, closing a stake of 434,803 shares — an estimated $14.2M sold.

Endurant Capital Management first reported a position in OFIX in Q2 2017 and held it in 4 quarters. The position peaked at $14.2M in Q1 2022. 130 funds tracked by Wall St. Rank hold OFIX as of Q2 2022.

Endurant Capital Management reported no remaining Orthofix Medical position as of Q2 2022 after selling out during the quarter.
Endurant Capital Management sold 434,803 Orthofix Medical shares in Q2 2022, an estimated $14.2M.
Endurant Capital Management first reported a position in Orthofix Medical in Q2 2017 and held it in 4 quarters.
Endurant Capital Management's Orthofix Medical position peaked at $14.2M in Q1 2022.
130 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.